Watch Ticker

DSS, Inc.

Go to DSS, Inc. Website

$0.99

-0.05 (-4.79%)

Live

Previous Close

$0.9901

Day Range

$0.9255 - $1.01

Previous Day Range

$0.99 - $1.0399

Market Cap

$9.5 million USD

Day Vol.

10841

Previous Day Vol.

33523

Currency

USD

Primary Exchange

NYSE American, LLC

DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the gl...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Globe Newswire - DSS, Inc.'s Subsidiary, Impact BioMedical Inc., Announces Strategic Merger

DSS, Inc. announced that its subsidiary, Impact BioMedical Inc., has entered into a definitive merger agreement with Dr. Ashleys Limited, a global pharmaceutical company. The transaction will result in a newly formed combined entity traded on the NYSE American under the name 'Dr Ashleys Limited'.

Related tickers: DSS, IBO.

Read Full Article

DSS, Inc. - Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled "Low Glycemic Sugar Composition."

NEW YORK, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Impact Biomedical Inc. (IBIO), in which DSS Inc.(NYSE American: DSS) has a significant investment, is thrilled to announce a milestone in its innovative Laetose™ technology platform. The U.S. Patent and Trademark Office (USPTO) has issued U.S. patent # 11,898,184, entitled "Low Glycemic Sugar Composition" developed within this platform.

Related tickers: DSS.

Read Full Article

Trending Tickers

Please sign in to view